Prototype of a DNA Vaccine against Marburg Virus

Bull Exp Biol Med. 2021 Feb;170(4):475-478. doi: 10.1007/s10517-021-05091-w. Epub 2021 Mar 13.

Abstract

The preparation and study of the biological properties of the pVAKS-GPVM DNA immunogen containing a gene encoding Marburgvirus glycoprotein are described. The specificity of blood serum antibodies of guinea pigs immunized with DNA immunogen was analyzed by ELISA. Inactivated viral preparation, recombinant glycoprotein (GP) obtained in the prokaryotic system and virus-like particles based on the recombinant vesicular stomatitis virus exhibiting Marburgvirus GP were used as the antigens. The neutralizing activity of antibodies of immunized animals was tested in vitro using a pseudovirus system. It was demonstrated that the developed immunogen administered to guinea pigs induced the production of specific antibodies that neutralize virus-like particles and Marburgvirus in cultured Vero cells.

Keywords: DNA immunogen; DNA vaccines; Marburg virus (MARV); Marburg virus glycoprotein.

MeSH terms

  • Animals
  • Antibodies, Neutralizing / immunology
  • Antibodies, Neutralizing / metabolism
  • Enzyme-Linked Immunosorbent Assay
  • Glycoproteins / immunology
  • Glycoproteins / metabolism
  • Immunoglobulins / immunology
  • Immunoglobulins / metabolism
  • Marburgvirus / immunology
  • Marburgvirus / pathogenicity*
  • Vaccines, DNA / therapeutic use*
  • Viral Proteins / immunology
  • Viral Proteins / metabolism

Substances

  • Antibodies, Neutralizing
  • Glycoproteins
  • Immunoglobulins
  • Vaccines, DNA
  • Viral Proteins